G01N 33/6854
Immunoglobulins
Official title: {Immunoglobulins}
G01N33/6854 (Immunoglobulins) appears on 2,427 US grants and 4,384 published applications in this corpus.
Search patents in G01N- Granted patents
- 2,427
- Published applications
- 4,384
- Assignees
- 1,833
- Inventors
- 8,455
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 4 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 8 | 0 |
| 1985 | 8 | 0 |
| 1986 | 4 | 0 |
| 1987 | 8 | 0 |
| 1988 | 7 | 0 |
| 1989 | 15 | 0 |
| 1990 | 18 | 0 |
| 1991 | 11 | 0 |
| 1992 | 11 | 0 |
| 1993 | 20 | 0 |
| 1994 | 11 | 0 |
| 1995 | 8 | 0 |
| 1996 | 17 | 0 |
| 1997 | 18 | 0 |
| 1998 | 27 | 0 |
| 1999 | 37 | 0 |
| 2000 | 29 | 0 |
| 2001 | 27 | 9 |
| 2002 | 19 | 52 |
| 2003 | 18 | 83 |
| 2004 | 22 | 72 |
| 2005 | 25 | 85 |
| 2006 | 29 | 82 |
| 2007 | 28 | 85 |
| 2008 | 39 | 100 |
| 2009 | 28 | 110 |
| 2010 | 62 | 133 |
| 2011 | 71 | 152 |
| 2012 | 66 | 136 |
| 2013 | 93 | 226 |
| 2014 | 83 | 208 |
| 2015 | 113 | 217 |
| 2016 | 133 | 238 |
| 2017 | 165 | 218 |
| 2018 | 132 | 209 |
| 2019 | 147 | 250 |
| 2020 | 165 | 265 |
| 2021 | 119 | 260 |
| 2022 | 125 | 234 |
| 2023 | 134 | 221 |
| 2024 | 113 | 318 |
| 2025 | 123 | 249 |
| 2026 | 79 | 172 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- High ionic strength dissociation assay for high drug tolerant testing22 Sep 2026US 12,742,785 B2Hoffmann-La Roche Inc.
- Multi-domain CD1a antagonist/PD-1 agonist antibody molecules15 Sep 2026US 12,735,491 B2Immunocore Limited
- Antigen for 2019 novel Coronavirus and detection use thereof15 Sep 2026US 12,736,543 B2Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
- Treatment of autoimmune liver disease15 Sep 2026US 12,736,544 B2The Governors of the University of Alberta
- Xseq8 Sep 2026US 12,729,460 B1Verily Health Inc.
- Homology-based cappers for blocking tau aggregation and identifying disease-specific tau filaments8 Oct 2026US 2026/0308210 A1University of Denver
- Antibody targeting dll3 and use of antibody8 Oct 2026US 2026/0308240 A1Neukio Biotherapeutics (Shanghai) Co., Ltd.
- Treatment of autoimmune diseases8 Oct 2026US 2026/0308244 A1UCB Developed Brands SRL
- Multi-domain molecules8 Oct 2026US 2026/0308260 A1Immunocore Limited
- Engineered Antibodies and Uses Thereof8 Oct 2026US 2026/0308277 A1Invitrogen Bioservices India Private Limited
Most cited
By later US patents
- Methods for producing members of specific binding pairs893US 5,969,108 ACambridge Antibody Technology Limited · 1999
- Polybifunctional reagent having a polymeric backbone and photoreactive moieties and bioactive groups478US 6,121,027 ASurModics, Inc. · 2000
- Modified antibody variable domains462US 5,766,886 AXoma Corporation · 1998
- Immunoassay with article having support film and immunological counterpart of analyte277US 4,444,879 AScience Research Center, Inc. · 1984
- Methods for producing members of specific binding pairs240US 5,871,907 ACambridge Antibody Technology Limited · 1999